Edison System for Pancreatic Tumors

About HistoSonics

HistoSonics is a private, clinical-stage medical device company pioneering the therapeutic application of histotripsy for non-invasive tumor ablation. Its lead platform, the Edison System, is designed for the treatment of liver tumors and is supported by ongoing clinical trials like #HOPE4KIDNEY and GANNON. The company has secured significant financing, completed key trial enrollment, and obtained initial insurance coverage, positioning it to advance towards regulatory approval and commercialization in the growing interventional oncology market.

Therapeutic Areas